Recombinant multi-species EED protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EED protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein interacts with enhancer of zeste 2, the cytoplasmic tail of integrin beta7, immunodeficiency virus type 1 (HIV-1) MA protein, and histone deacetylase proteins. This protein mediates repression of gene activity through histone deacetylation, and may act as a specific regulator of integrin function. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: COGIS,EED,Eed,Embryonic ectoderm development protein,HEED,Polycomb protein EED,WAIT1,WD protein associating with integrin cytoplasmic tails 1 (WAIT-1),hEED,l(7)5Rn,l7Rn5,lusk

Target products collectionGo to EED products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T44916-Ag-1/ GM-Tg-hg-T44916-Ag-2 Human EED protein Human
GM-Tg-rg-T44916-Ag-1/ GM-Tg-rg-T44916-Ag-2 Rat EED protein Rat
GM-Tg-mg-T44916-Ag-1/ GM-Tg-mg-T44916-Ag-2 Mouse EED protein Mouse
GM-Tg-cynog-T44916-Ag-1/ GM-Tg-cynog-T44916-Ag-2 Cynomolgus/Rhesus macaque EED protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T44916-Ag-1/ GM-Tg-felg-T44916-Ag-2 Feline EED protein Feline
GM-Tg-cang-T44916-Ag-1/ GM-Tg-cang-T44916-Ag-2 Canine EED protein Canine
GM-Tg-bovg-T44916-Ag-1/ GM-Tg-bovg-T44916-Ag-2 Bovine EED protein Bovine
GM-Tg-equg-T44916-Ag-1/ GM-Tg-equg-T44916-Ag-2 Equine EED protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T44916-Ag-1/ GM-Tg-hg-T44916-Ag-2; GM-Tg-rg-T44916-Ag-1/ GM-Tg-rg-T44916-Ag-2;
GM-Tg-mg-T44916-Ag-1/ GM-Tg-mg-T44916-Ag-2; GM-Tg-cynog-T44916-Ag-1/ GM-Tg-cynog-T44916-Ag-2;
GM-Tg-felg-T44916-Ag-1/ GM-Tg-felg-T44916-Ag-2; GM-Tg-cang-T44916-Ag-1/ GM-Tg-cang-T44916-Ag-2;
GM-Tg-bovg-T44916-Ag-1/ GM-Tg-bovg-T44916-Ag-2; GM-Tg-equg-T44916-Ag-1/ GM-Tg-equg-T44916-Ag-2
Products Name EED protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name EED
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EED protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.